SuperNOVA Clinical Stenting Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 299 participants.

Also called NCT01292928

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 299 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01292928
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Austria, Belgium, Canada, Germany, Japan, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01292928. Allocation not applicable; no masking; primary purpose treatment. Start 2011-04 (registry gives no type); primary completion 2014-07 (actual). Results posted on 2016-01-20.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
SuperNOVA Clinical Stenting Trial
Condition
Atherosclerosis of Native Arteries of the Extremities, Unspecified
Intervention (Device)
Stent implantation
Lead sponsor
Boston Scientific Corporation (class: industry)

Record details

Record id
cardio:ct-nct01292928
Content hash
40f3966065f7d30c455f2f73c7278adc5d4dcdeb201a2e5f9550716a91d573a6